(A) Control hTECs show a normal ellipsoid shape and clear contour. (B) Exposure to TGF-β (2 ng/ml) induced bursting and speckled morphological changes in hTECs. (C) Exposure to TGF-β (2 ng/ml) in the presence of p38 MAPK inhibitor (2 μM). (D) Exposure to TGF-β (2 ng/ml) in the presence of p38 MAPK inhibitor (4 μM).</p
<p>(A) and (B) Activation of p38, Src and ERK½ was determined in HUVECs treated with VEGF or pro-inf...
<p>A: Untreated Eca109 and KYSE150 cells, 100×; B,C: Eca109 and KYSE150 cells treated with TGF-β1 (1...
<p>(<b>A</b>) Lysates from Huh7.5 or Huh7.5-FL cells collected at the indicated time points were blo...
(A) COL1 expression was increased after exposure to TGF-β (2 ng/ml). Treatment with the p38 MAPK inh...
Representative photomicrographs of FPTEC, HREC and HK-2 after incubation with vehicle and 0.1–10 ng/...
<p>The cobblestone-like appearance of HPMCs was converted into a fibroblast-like morphology 72 hr af...
<p>Where indicated, the p-p38 inhibitor SB203580 or the TGFβR-SMAD2/3 inhibitor SB431542 was added i...
<p>(A) hPTECs were seeded at passage 1 at low (25 000 cells/cm<sup>2</sup>) or high density (75 000 ...
<p>A) Immunoblot analysis of the effects of H-1152 (top) or Y-27632 (bottom) concentration on induct...
<p>A) MCF7 cells were treated with the EGF domain of HRG-β1 (100 ng/ml) for 24 h in the presence or ...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p><b>a</b>. Immunostaining for the cytoskeleton component F-actin, shows a confluent monolayer char...
<p>A. Demonstration of the effect of the p38 inhibitor (SB202190) and JNK inhibitor (SP600125), each...
<p>(A) Representative images of paxillin (green) and F-actin (red) localization in keratinocytes tre...
<p>To test TJ integrity, embryos were treated in KSOMaa, SB 202474, or SB 220025 then exposed to 40 ...
<p>(A) and (B) Activation of p38, Src and ERK½ was determined in HUVECs treated with VEGF or pro-inf...
<p>A: Untreated Eca109 and KYSE150 cells, 100×; B,C: Eca109 and KYSE150 cells treated with TGF-β1 (1...
<p>(<b>A</b>) Lysates from Huh7.5 or Huh7.5-FL cells collected at the indicated time points were blo...
(A) COL1 expression was increased after exposure to TGF-β (2 ng/ml). Treatment with the p38 MAPK inh...
Representative photomicrographs of FPTEC, HREC and HK-2 after incubation with vehicle and 0.1–10 ng/...
<p>The cobblestone-like appearance of HPMCs was converted into a fibroblast-like morphology 72 hr af...
<p>Where indicated, the p-p38 inhibitor SB203580 or the TGFβR-SMAD2/3 inhibitor SB431542 was added i...
<p>(A) hPTECs were seeded at passage 1 at low (25 000 cells/cm<sup>2</sup>) or high density (75 000 ...
<p>A) Immunoblot analysis of the effects of H-1152 (top) or Y-27632 (bottom) concentration on induct...
<p>A) MCF7 cells were treated with the EGF domain of HRG-β1 (100 ng/ml) for 24 h in the presence or ...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p><b>a</b>. Immunostaining for the cytoskeleton component F-actin, shows a confluent monolayer char...
<p>A. Demonstration of the effect of the p38 inhibitor (SB202190) and JNK inhibitor (SP600125), each...
<p>(A) Representative images of paxillin (green) and F-actin (red) localization in keratinocytes tre...
<p>To test TJ integrity, embryos were treated in KSOMaa, SB 202474, or SB 220025 then exposed to 40 ...
<p>(A) and (B) Activation of p38, Src and ERK½ was determined in HUVECs treated with VEGF or pro-inf...
<p>A: Untreated Eca109 and KYSE150 cells, 100×; B,C: Eca109 and KYSE150 cells treated with TGF-β1 (1...
<p>(<b>A</b>) Lysates from Huh7.5 or Huh7.5-FL cells collected at the indicated time points were blo...